MedPath

LETROZOL AUROVITAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

LETROZOL AUROVITAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

85626

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Dec 30, 2020

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number85626
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LETROZOLActive
Quantity: 2,5 mg
Name: LETROZOL

ATC CLASSIFICATION (3)

L02B
L02BG
L02BG04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.